Related references
Note: Only part of the references are listed.Challenges and successes in developing new therapies for hepatitis C
R De Francesco et al.
NATURE (2005)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
KL Lindsay et al.
HEPATOLOGY (2001)
Pegylated interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
P Glue et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)